{"gene":"MFN1","run_date":"2026-04-28T18:30:28","timeline":{"discoveries":[{"year":2003,"finding":"MFN1 and MFN2 form homotypic and heterotypic complexes on the mitochondrial outer membrane and are essential for mitochondrial fusion; cells lacking Mfn1 or Mfn2 show severely reduced mitochondrial fusion, and homotypic complexes of each mitofusin are functional for fusion. Loss of either causes mitochondrial fragmentation and loss of membrane potential in a subset of mitochondria.","method":"Knockout mouse embryonic fibroblasts, rescue experiments with individual Mfn expression, mitochondrial morphology assays (live imaging), membrane potential measurements","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal genetic rescue, KO fibroblasts with defined fusion phenotype, replicated across two paralogs; foundational paper with >2000 citations","pmids":["12527753"],"is_preprint":false},{"year":2007,"finding":"Wild-type MFN1 can complement CMT2A disease-causing MFN2 mutants through formation of heterooligomeric complexes in trans between mitochondria, restoring fusion activity. Wild-type MFN2 cannot complement the same disease alleles, establishing a functional asymmetry between the two paralogs.","method":"Complementation assays in Mfn1/Mfn2 mutant MEFs, co-immunoprecipitation of heterooligomeric complexes, mitochondrial fusion assays","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — functional rescue and co-IP in defined mutant cells, orthogonal methods, >280 citations","pmids":["17296794"],"is_preprint":false},{"year":2017,"finding":"Crystal structures of engineered human MFN1 (GTPase domain + helical domain) reveal that GTP binding induces conformational changes promoting GTPase domain dimerization in the transition state. The helical domain resembles the 'neck' of bacterial dynamin-like proteins. A conserved aspartate residue acts as a trigger affecting mitochondrial elongation through GTP-loading-dependent domain rearrangement. Disruption of GTPase domain dimerization abolishes MFN1 fusogenic activity.","method":"X-ray crystallography of engineered MFN1 constructs in multiple nucleotide states, active-site mutagenesis, mitochondrial fusion assays in cells","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structures at multiple catalytic states combined with mutagenesis and functional fusion assays in a single study","pmids":["28114303"],"is_preprint":false},{"year":2010,"finding":"MFN1 associates with IPS-1 (MAVS) on the mitochondrial outer membrane and positively regulates RLR-mediated innate antiviral responses. Knockdown of MFN1 abrogates virus-induced redistribution of IPS-1 into speckle-like aggregates and abolishes IFN production.","method":"siRNA knockdown of MFN1, immunofluorescence for IPS-1 redistribution, IFN production assays upon viral infection or 5'ppp-RNA transfection","journal":"PLoS pathogens","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined functional phenotype (IFN production, IPS-1 redistribution), single lab","pmids":["20661427"],"is_preprint":false},{"year":2014,"finding":"Upon glucose starvation, MFN1 associates with the deacetylase HDAC6, leading to MFN1 deacetylation and activation, which promotes mitochondrial fusion to suppress oxidative stress. HDAC6-deficient cells fail to undergo fusion-induced protection. An acetylation-resistant MFN1 mutant suppresses excess ROS production. In fasting mice, skeletal muscle mitochondria undergo dramatic fusion that is abrogated in HDAC6-knockout animals.","method":"Co-immunoprecipitation (MFN1-HDAC6), acetylation-resistant MFN1 mutant rescue, ROS measurements, mitochondrial morphology assays, HDAC6-KO mouse fasting model","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — Co-IP, acetylation mutant rescue, in vivo KO model, multiple orthogonal methods in single study","pmids":["25271058"],"is_preprint":false},{"year":2014,"finding":"MARCH5 E3 ubiquitin ligase binds MFN1 and ubiquitylates it in a manner dependent on MFN1 acetylation at K491; the acetylation-deficient K491R mutant shows weak MARCH5 interaction and reduced ubiquitylation, whereas the acetylation-mimetic K491Q mutant does not. MARCH5-mediated quality control on acetylated MFN1 maintains appropriate MFN1 levels for cell survival under mitochondrial stress.","method":"Co-immunoprecipitation (MARCH5-MFN1), acetylation point mutants (K491R, K491Q), ubiquitylation assays, MARCH5-KO MEFs","journal":"Cell death & disease","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, mutagenesis of acetylation site, KO cells with functional phenotype","pmids":["24722297"],"is_preprint":false},{"year":2017,"finding":"SIRT1 deacetylase stabilizes MFN1 protein; its knockdown reduces MFN1 levels while SIRT1 overexpression increases them. TIP60 acetyltransferase promotes MFN1 acetylation and reduction, an effect abolished by co-expression of SIRT1. Under hypoxia, SIRT1 and MFN1 accumulate together, driving mitochondrial elongation. In vitro acetylation assays confirm TIP60 acetylates MFN1.","method":"siRNA knockdown and overexpression of SIRT1, in vitro acetylation assays, mitochondrial morphology assays under hypoxia","journal":"Cellular signalling","confidence":"Medium","confidence_rationale":"Tier 2 — in vitro acetylation assay plus KD/OE with phenotype, single lab","pmids":["28669827"],"is_preprint":false},{"year":2009,"finding":"In C. elegans, the BCL-2-like protein CED-9 physically interacts with FZO-1 (the Mfn1/2 homologue) in vivo and promotes complete mitochondrial fusion (outer and inner membranes) in an FZO-1/Mfn1,2- and EAT-3/Opa1-dependent manner. Disruption of CED-9's ability to interact with FZO-1 impairs its ability to cause mitochondrial fusion.","method":"C. elegans genetics, in vivo co-immunoprecipitation (CED-9 with FZO-1), mitochondrial morphology assays, genetic epistasis with fzo-1 and eat-3 mutants","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — in vivo Co-IP plus genetic epistasis in model organism ortholog context","pmids":["19704021"],"is_preprint":false},{"year":2017,"finding":"Rapid degradation of SLC25A46 by the ubiquitin-proteasome system (via E3 ligases MULAN and MARCH5, with P97 and proteasome) results in increased stability and oligomerization of MFN1 and MFN2 on the mitochondrial outer membrane, promoting mitochondrial hyperfusion. SLC25A46 thus acts as a regulator of MFN1/2 oligomerization.","method":"siRNA knockdown of SLC25A46, protein stability assays, mitochondrial morphology assays, ubiquitylation assays with MULAN and MARCH5","journal":"Molecular biology of the cell","confidence":"Medium","confidence_rationale":"Tier 2 — KD with defined fusion phenotype and mechanistic follow-up on MFN1 oligomerization, single lab","pmids":["28057766"],"is_preprint":false},{"year":2021,"finding":"STING1 accumulates in mitochondria upon erastin-induced ferroptosis and binds MFN1/2 to trigger mitochondrial fusion, leading to ROS production and lipid peroxidation. Genetic depletion of MFN1/2 (but not PINK1 or PRKN) reduces pancreatic cancer cell sensitivity to ferroptosis.","method":"Co-immunoprecipitation (STING1 with MFN1/2), genetic KO of MFN1/2, ferroptosis assays (lipid peroxidation, cell death), xenograft mouse models","journal":"Frontiers in cell and developmental biology","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus genetic KO with defined ferroptosis phenotype, single lab","pmids":["34195205"],"is_preprint":false},{"year":2022,"finding":"FUNDC2 directly interacts with the GTPase domain of MFN1 via its amino-terminal region, inhibiting MFN1 GTPase activity and outer mitochondrial membrane fusion. Loss of FUNDC2 leads to mitochondrial elongation and reprogrammed cellular metabolism.","method":"Co-immunoprecipitation, domain mapping, GTPase activity assay, FUNDC2 knockdown/KO with mitochondrial morphology and metabolic phenotype","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro GTPase assay, domain mapping, co-IP, and KO with defined phenotype","pmids":["35710796"],"is_preprint":false},{"year":2022,"finding":"MFN1 and MFN2 promote clustering between mitochondria and peroxisomes and are enriched at the mitochondria-peroxisome interface. Overexpression of MFNs increases mitochondria-peroxisome contacting sites, and a truncated MFN2 lacking the transmembrane region inhibits peroxisome tethering to mitochondria.","method":"Proximity labeling (BioID) with peroxisomal proteins, live-cell imaging of co-clustering, truncation mutant expression","journal":"Communications biology","confidence":"Medium","confidence_rationale":"Tier 2 — proximity labeling plus live imaging and dominant-negative mutant, single lab","pmids":["35523862"],"is_preprint":false},{"year":2016,"finding":"Liver-specific deletion of Mfn1 (Mfn1LKO) produces a highly fragmented mitochondrial network coupled with enhanced mitochondrial respiration capacity, preference for lipid oxidation, and increased complex I abundance. Mfn1LKO mice are protected against diet-induced insulin resistance and sensitized to metformin's hypoglycemic effect.","method":"Liver-specific conditional KO mice, mitochondrial morphology assays (electron microscopy), oxygen consumption measurements, insulin tolerance tests, metformin treatment","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific KO with multiple orthogonal metabolic and morphological phenotypes","pmids":["27613809"],"is_preprint":false},{"year":2022,"finding":"β-cell-specific double KO of Mfn1 and Mfn2 reduces mitochondrial length, glucose-induced mitochondrial polarization, ATP synthesis, and cytosolic/mitochondrial Ca2+ increases, impairing glucose-stimulated insulin secretion. Incretin/GLP-1 receptor agonists correct defective secretion through enhanced EPAC-dependent cAMP signaling, bypassing the mitochondrial defect.","method":"β-cell-selective adult-restricted dKO mice, mitochondrial morphology, ATP synthesis assays, Ca2+ imaging, cAMP sensor (Epac-camps), insulin secretion assays","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 — conditional dKO with multiple orthogonal physiological and imaging readouts","pmids":["35472764"],"is_preprint":false},{"year":2024,"finding":"REEP5, an ER tubule-shaping protein, interacts with MFN1/2 to mediate mitochondrial 'hitchhiking' on tubular ER along microtubules. REEP5 depletion causes reduced ER-mitochondria tethering and increased perinuclear mitochondrial localization. Forced irreversible REEP5-MFN1/2 interaction via rapamycin-induced dimerization causes mitochondrial hyperfusion. Disruption of this interaction modulates mitochondrial ROS production.","method":"Co-immunoprecipitation (REEP5 with MFN1/2), live-cell imaging of mitochondrial distribution, rapamycin-inducible forced dimerization, REEP5 siRNA KD, ROS measurements","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, chemogenetic forced interaction, live imaging with functional consequence on ROS","pmids":["39133213"],"is_preprint":false},{"year":2016,"finding":"MARCH5 mediates ubiquitin-dependent degradation of MFN1 in response to tributyltin (TBT) exposure, causing mitochondrial fragmentation. Knockdown of MARCH5 abolishes TBT-induced MFN1 degradation in iPSCs.","method":"siRNA knockdown of MARCH5, MFN1 protein level assays, MitoTracker mitochondrial morphology, ATP measurements in human iPSCs","journal":"Toxicology in vitro","confidence":"Medium","confidence_rationale":"Tier 3 — single KD experiment with protein level and morphology readout, mechanistically limited","pmids":["27133438"],"is_preprint":false},{"year":2022,"finding":"MFN1 interacts with BAK and with OPA1; in tamoxifen-resistant breast cancer cells, MFN1-BAK interaction is increased restraining BAK activation, while MFN1-OPA1 interaction is reduced due to augmented OPA1 proteolytic cleavage. Knockdown or pharmacological inhibition of MFN1 restores BAK oligomerization, cytochrome c release, and caspase-3/9 activation, re-sensitizing resistant cells to apoptosis.","method":"Co-immunoprecipitation (MFN1-MFN2, MFN1-OPA1, MFN1-BAK), siRNA knockdown, pharmacological inhibition, cytochrome c release assay, caspase activity assay, xenograft models","journal":"Cancer letters","confidence":"Medium","confidence_rationale":"Tier 2 — multiple Co-IPs plus functional rescue, single lab","pmids":["38583647"],"is_preprint":false},{"year":2024,"finding":"Cadmium induces Parkin mitochondrial translocation, which promotes ubiquitin-dependent degradation of MFN1 protein, causing mitochondrial fusion disorder and suppressing testosterone synthesis in Leydig cells. Testis-specific Parkin knockdown prevents MFN1 degradation and mitigates testosterone decline. Mito-TEMPO (mtROS inhibitor) blocks Parkin translocation and MFN1 degradation.","method":"Parkin testis-specific KD, MFN1 overexpression, ubiquitination assays, mitochondrial morphology, testosterone measurements, Mito-TEMPO treatment in mouse model","journal":"Journal of hazardous materials","confidence":"Medium","confidence_rationale":"Tier 2 — KD plus OE with mechanistic follow-up on ubiquitination, single lab","pmids":["38555669"],"is_preprint":false},{"year":2024,"finding":"Endogenous interactome profiling of MFN1-HA (CRISPR-tagged) by mass spectrometry identified novel ER, endosomal, and mitochondrial interactors of MFN1. RAB5C was validated as an endosomal modulator of mitochondrial homeostasis in interaction with MFN1/2. Interactors are regulated by nutrient deprivation.","method":"CRISPR-Cas9 endogenous HA-tagging of MFN1, HA-affinity pulldown mass spectrometry, nutrient deprivation conditions, validation of novel interactors","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — endogenous-level interactome by MS with functional validation, single lab","pmids":["39675054"],"is_preprint":false},{"year":2022,"finding":"βIIPKC (protein kinase C βII) accumulates on the mitochondrial outer membrane, phosphorylates MFN1 at serine 86, and increases the MFN1-βIIPKC interaction after subarachnoid hemorrhage (SAH). A selective peptide antagonist of MFN1-βIIPKC association (SAMβA) attenuates neuronal injury, mitochondrial dysfunction, and protects Sirt3-dependent antioxidant activity.","method":"Co-immunoprecipitation (MFN1-βIIPKC), βIIPKC inhibitor and SAMβA peptide treatment, mitochondrial function assays, Sirt3 siRNA knockdown, in vitro and in vivo SAH models","journal":"Translational stroke research","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus selective peptide antagonist with defined functional phenotype, single lab","pmids":["35192161"],"is_preprint":false},{"year":2022,"finding":"Protodioscin (PD) induces formation of an MFN1-Bak-IP3R complex on mitochondria, facilitating Ca2+ transfer from ER to mitochondria and triggering apoptosis. Downregulation of either MFN1 or Bak reverses PD-induced apoptosis and mitochondrial membrane potential loss.","method":"Co-immunoprecipitation (MFN1-Bak-IP3R), siRNA knockdown of MFN1 and Bak, flow cytometry apoptosis assay, mitochondrial membrane potential measurement","journal":"Journal of hepatocellular carcinoma","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP of tripartite complex plus KD with functional phenotype, single lab","pmids":["35496076"],"is_preprint":false},{"year":2025,"finding":"Using time-resolved tmFRET in solution, GTP binding to MFN1 favors the open state (GTPase and HB1 domains far apart), while GDP+Pi results in an equilibrium between open and closed states. The nucleotide-free (apo) state adopts a conformation distinct from all nucleotide-bound states. These solution measurements reveal the full conformational cycle of MFN1 during GTP hydrolysis.","method":"Time-resolved transition metal ion FRET (tmFRET) with fluorescent non-canonical amino acid donors and metal ion acceptors, fluorescence lifetime measurements, distance distribution analysis across GDP-, GDP+Pi-, GTP-bound, and apo states","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 — rigorous biophysical assay capturing full catalytic cycle in solution; preprint, not yet peer-reviewed","pmids":[],"is_preprint":true},{"year":2025,"finding":"Mitochondrial 'pull-out'—lateral extrusion from pre-existing mitochondrial tubules generating new mitochondrial ends as preferential fusion sites—requires both MFN1 and DRP1, and occurs predominantly at ER-mitochondria contact sites. Pull-out events are stimulated by conditions favoring oxidative phosphorylation.","method":"Live-cell imaging, MFN1 and DRP1 KO/KD, ER-mitochondria contact site visualization, metabolic perturbations","journal":"bioRxiv","confidence":"Low","confidence_rationale":"Tier 3 — preprint, mechanistic assignment relies on KO and live imaging without full reconstitution","pmids":[],"is_preprint":true}],"current_model":"MFN1 is a dynamin-related GTPase anchored in the mitochondrial outer membrane that mediates mitochondrial fusion through GTP-hydrolysis-driven conformational changes (open↔closed) promoting GTPase domain dimerization in trans between adjacent mitochondria; it forms homotypic and heterotypic complexes with MFN2, is regulated post-translationally by acetylation (written by TIP60, erased by HDAC6/SIRT1) and ubiquitylation (by MARCH5/Parkin/HRD1), interacts with IPS-1/MAVS to support antiviral signaling, with BAK and OPA1 to regulate apoptotic cytochrome c release, and with REEP5 to mediate ER-mitochondria tethering and mitochondrial cytosolic distribution."},"narrative":{"teleology":[{"year":2003,"claim":"Establishing that mammalian mitochondrial fusion requires dedicated outer-membrane GTPases resolved how mitochondrial morphology is maintained: MFN1 and MFN2 are each essential, form functional homotypic and heterotypic complexes, and their loss causes fragmentation and loss of membrane potential.","evidence":"Mfn1 and Mfn2 KO MEFs with rescue experiments, live imaging of mitochondrial fusion","pmids":["12527753"],"confidence":"High","gaps":["Relative contribution of homotypic vs heterotypic complexes in vivo not quantified","Mechanism of GTP hydrolysis in fusion not yet defined"]},{"year":2007,"claim":"Demonstrating that MFN1 can complement CMT2A-linked MFN2 mutants in trans while MFN2 cannot revealed a functional asymmetry between paralogs, establishing MFN1 as the dominant fusogenic subunit in heterotypic complexes.","evidence":"Complementation assays in Mfn-null MEFs, co-immunoprecipitation of heterooligomers","pmids":["17296794"],"confidence":"High","gaps":["Structural basis for paralog asymmetry unknown","Whether asymmetry holds in all tissues not tested"]},{"year":2009,"claim":"Showing that the BCL-2-family protein CED-9 physically engages FZO-1/Mfn and promotes fusion in a FZO-1- and EAT-3/OPA1-dependent manner linked apoptotic regulators to the mitochondrial fusion machinery.","evidence":"C. elegans in vivo co-IP of CED-9 with FZO-1, genetic epistasis with fzo-1 and eat-3 mutants","pmids":["19704021"],"confidence":"High","gaps":["Direct mammalian BCL-2/MFN1 interaction not fully recapitulated at this point","Whether CED-9 activates or simply stabilizes FZO-1 unclear"]},{"year":2010,"claim":"Identifying MFN1 as a positive regulator of MAVS/IPS-1 aggregation and interferon production expanded MFN1's role beyond fusion to innate antiviral signaling on the mitochondrial outer membrane.","evidence":"MFN1 siRNA knockdown, MAVS redistribution imaging, IFN production assays upon viral challenge","pmids":["20661427"],"confidence":"Medium","gaps":["Whether MFN1's GTPase activity is required for MAVS signaling untested","Physical binding interface between MFN1 and MAVS unmapped"]},{"year":2014,"claim":"Discovery that HDAC6 deacetylates MFN1 under glucose starvation to activate fusion, while MARCH5 ubiquitylates acetylated MFN1 (at K491) for degradation, established acetylation as a central regulatory switch controlling MFN1 activity and turnover.","evidence":"Co-IP of MFN1-HDAC6, acetylation-site mutants, ROS assays, HDAC6-KO mouse fasting model; MARCH5-MFN1 co-IP and K491R/Q mutant ubiquitylation assays in KO MEFs","pmids":["25271058","24722297"],"confidence":"High","gaps":["Full acetylation site map of MFN1 not determined","Whether acetylation alters GTPase domain conformation unknown"]},{"year":2016,"claim":"Liver-specific Mfn1 deletion revealed that mitochondrial fragmentation paradoxically enhances respiratory capacity and lipid oxidation, protecting against diet-induced insulin resistance, demonstrating tissue-specific metabolic consequences of MFN1 loss.","evidence":"Liver-specific conditional KO mice, electron microscopy, respirometry, insulin tolerance tests","pmids":["27613809"],"confidence":"High","gaps":["How fragmented mitochondria sustain enhanced respiration mechanistically unclear","Whether phenotype depends on compensatory MFN2 activity not addressed"]},{"year":2017,"claim":"Crystal structures of MFN1 in multiple nucleotide states defined the GTP-hydrolysis-driven conformational cycle: GTP binding promotes GTPase domain dimerization in the transition state through a conserved aspartate trigger, directly coupling catalysis to membrane tethering.","evidence":"X-ray crystallography of engineered MFN1 constructs, active-site mutagenesis, cellular fusion assays","pmids":["28114303"],"confidence":"High","gaps":["Full-length MFN1 structure not solved","Lipid membrane context absent from crystallographic constructs","How dimerization generates force for membrane merger not resolved"]},{"year":2017,"claim":"Identification of SLC25A46 as a negative regulator of MFN1/2 oligomerization showed that MFN1 activity is modulated not only by direct post-translational modifications but also by adjacent membrane proteins controlling its oligomeric state.","evidence":"SLC25A46 knockdown, MFN1 oligomerization and stability assays, mitochondrial morphology","pmids":["28057766"],"confidence":"Medium","gaps":["Direct physical interaction between SLC25A46 and MFN1 not demonstrated","Mechanism of oligomerization control unclear"]},{"year":2017,"claim":"Showing that SIRT1 deacetylates and stabilizes MFN1 while TIP60 acetylates it completed the writer-eraser cycle for MFN1 acetylation, linking hypoxic stress to mitochondrial elongation.","evidence":"SIRT1 KD/OE, in vitro TIP60 acetylation assays, mitochondrial morphology under hypoxia","pmids":["28669827"],"confidence":"Medium","gaps":["Whether TIP60 and HDAC6 act on the same or overlapping sites not resolved","In vivo relevance of SIRT1-MFN1 axis beyond cell culture not shown"]},{"year":2022,"claim":"Multiple studies converged to show MFN1 integrates diverse signaling inputs: FUNDC2 directly inhibits MFN1 GTPase activity, βIIPKC phosphorylates MFN1 at S86, MFN1 interaction with BAK restrains apoptosis, and STING1 engages MFN1 to promote ferroptosis-associated fusion, revealing MFN1 as a signaling hub on the outer membrane.","evidence":"GTPase activity assays and domain mapping for FUNDC2; co-IP of MFN1-βIIPKC with peptide antagonist; co-IP of MFN1-BAK/OPA1 with KD rescue of apoptosis; co-IP of STING1-MFN1 with KO ferroptosis assays","pmids":["35710796","35192161","38583647","34195205"],"confidence":"Medium","gaps":["Whether phosphorylation and acetylation sites interact allosterically unknown","Structural basis for FUNDC2 inhibition of GTPase domain unresolved","MFN1-BAK findings limited to tamoxifen-resistant breast cancer context"]},{"year":2022,"claim":"β-cell-specific double KO of Mfn1/Mfn2 demonstrated that mitofusin-dependent fusion is required for glucose-stimulated ATP production and insulin secretion, a defect bypassable by incretin signaling through cAMP/EPAC.","evidence":"Adult β-cell-selective conditional dKO mice, ATP synthesis, Ca2+ imaging, insulin secretion assays","pmids":["35472764"],"confidence":"High","gaps":["Individual contributions of MFN1 vs MFN2 in β-cells not separated","Long-term β-cell survival consequences not assessed"]},{"year":2022,"claim":"Demonstration that MFN1/2 are enriched at mitochondria-peroxisome contact sites and promote interorganellar clustering extended MFN1's tethering role beyond homotypic mitochondrial fusion.","evidence":"BioID proximity labeling with peroxisomal markers, live-cell imaging, dominant-negative truncation mutant","pmids":["35523862"],"confidence":"Medium","gaps":["Direct MFN1-peroxisomal receptor interaction not identified","Functional consequence of mitochondria-peroxisome tethering on lipid metabolism not tested"]},{"year":2024,"claim":"Discovery that REEP5 interacts with MFN1/2 to mediate ER-mitochondria tethering and microtubule-based mitochondrial 'hitchhiking' revealed a mechanism for cytoplasmic distribution of mitochondria coupled to ER dynamics.","evidence":"Reciprocal co-IP (REEP5-MFN1/2), rapamycin-inducible forced dimerization, live-cell imaging, ROS measurements","pmids":["39133213"],"confidence":"High","gaps":["Binding interface between REEP5 and MFN1 unmapped","Whether REEP5 modulates MFN1 GTPase activity unknown"]},{"year":2024,"claim":"Endogenous MFN1 interactome profiling uncovered nutrient-regulated associations with ER, endosomal (RAB5C), and mitochondrial partners, broadening the landscape of MFN1 interorganellar contacts.","evidence":"CRISPR-tagged endogenous MFN1-HA affinity MS, validation of RAB5C, nutrient deprivation conditions","pmids":["39675054"],"confidence":"Medium","gaps":["Most novel interactors lack functional validation","Whether RAB5C-MFN1 interaction is direct or bridged by adaptors untested"]},{"year":null,"claim":"A full-length MFN1 structure in a membrane context, the force-generating mechanism by which GTPase dimerization drives lipid bilayer merger, and the integrative logic by which acetylation, phosphorylation, and ubiquitylation combinatorially regulate MFN1 activity remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No full-length structure of membrane-embedded MFN1","Reconstituted fusion assay with purified MFN1 not achieved","Combinatorial post-translational modification code not mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[2,10,21]}],"localization":[{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0,2,5,10,14]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,14]}],"pathway":[{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[0,1,2,10,12]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[7,16,20]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[3]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[12,13]}],"complexes":["MFN1-MFN2 heterotypic complex","MFN1 homotypic trans-dimer"],"partners":["MFN2","FUNDC2","REEP5","MARCH5","HDAC6","BAK1","OPA1","MAVS"],"other_free_text":[]},"mechanistic_narrative":"MFN1 is a dynamin-related GTPase anchored in the mitochondrial outer membrane that drives mitochondrial fusion through GTP-hydrolysis-dependent conformational cycling and trans-dimerization of its GTPase domains between apposing organelles [PMID:28114303]. MFN1 forms both homotypic complexes and heterotypic complexes with MFN2, with a functional asymmetry whereby MFN1 can complement disease-causing MFN2 alleles but not vice versa [PMID:12527753, PMID:17296794]. Its fusogenic activity is tuned by post-translational modifications—acetylation (written by TIP60, erased by HDAC6 and SIRT1) modulates its stability and activity, while ubiquitylation by MARCH5 and Parkin targets it for proteasomal degradation—and by direct inhibitory binding of FUNDC2 to the GTPase domain [PMID:25271058, PMID:24722297, PMID:35710796]. Beyond mitochondrial fusion, MFN1 participates in ER–mitochondria tethering via REEP5, supports MAVS-dependent innate antiviral signaling, modulates BAK-dependent apoptotic cytochrome c release, and influences metabolic homeostasis including hepatic lipid oxidation and β-cell insulin secretion [PMID:39133213, PMID:20661427, PMID:38583647, PMID:27613809, PMID:35472764]."},"prefetch_data":{"uniprot":{"accession":"Q8IWA4","full_name":"Mitofusin-1","aliases":["Fzo homolog","Transmembrane GTPase MFN1"],"length_aa":741,"mass_kda":84.2,"function":"Mitochondrial outer membrane GTPase that mediates mitochondrial clustering and fusion (PubMed:12475957, PubMed:12759376, PubMed:27920125, PubMed:28114303). Membrane clustering requires GTPase activity (PubMed:27920125). It may involve a major rearrangement of the coiled coil domains (PubMed:27920125, PubMed:28114303). Mitochondria are highly dynamic organelles, and their morphology is determined by the equilibrium between mitochondrial fusion and fission events (PubMed:12475957, PubMed:12759376). Overexpression induces the formation of mitochondrial networks (in vitro) (PubMed:12759376). Has low GTPase activity (PubMed:27920125, PubMed:28114303)","subcellular_location":"Cytoplasm","url":"https://www.uniprot.org/uniprotkb/Q8IWA4/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/MFN1","classification":"Not Classified","n_dependent_lines":14,"n_total_lines":1208,"dependency_fraction":0.011589403973509934},"opencell":{"profiled":true,"resolved_as":"","ensg_id":"ENSG00000171109","cell_line_id":"CID000818","localizations":[{"compartment":"mitochondria","grade":3}],"interactors":[{"gene":"MFN2","stoichiometry":4.0},{"gene":"SYAP1","stoichiometry":0.2},{"gene":"PSMC6","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/target/CID000818","total_profiled":1310},"omim":[{"mim_id":"620739","title":"RCC1-LIKE PROTEIN; RCC1L","url":"https://www.omim.org/entry/620739"},{"mim_id":"618817","title":"TRANSMEMBRANE PROTEIN 11; TMEM11","url":"https://www.omim.org/entry/618817"},{"mim_id":"618802","title":"tRNA-HISTIDINE GUANYLYLTRANSFERASE 1-LIKE PROTEIN; THG1L","url":"https://www.omim.org/entry/618802"},{"mim_id":"617081","title":"OMA1 ZINC METALLOPEPTIDASE; OMA1","url":"https://www.omim.org/entry/617081"},{"mim_id":"616636","title":"IMMUNODEFICIENCY 44; IMD44","url":"https://www.omim.org/entry/616636"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Mitochondria","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/MFN1"},"hgnc":{"alias_symbol":["FLJ20693"],"prev_symbol":[]},"alphafold":{"accession":"Q8IWA4","domains":[{"cath_id":"3.40.50.300","chopping":"76-308","consensus_level":"medium","plddt":87.6817,"start":76,"end":308},{"cath_id":"-","chopping":"378-536_617-695","consensus_level":"medium","plddt":80.909,"start":378,"end":695}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWA4","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWA4-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8IWA4-F1-predicted_aligned_error_v6.png","plddt_mean":81.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=MFN1","jax_strain_url":"https://www.jax.org/strain/search?query=MFN1"},"sequence":{"accession":"Q8IWA4","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8IWA4.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8IWA4/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8IWA4"}},"corpus_meta":[{"pmid":"12527753","id":"PMC_12527753","title":"Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development.","date":"2003","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/12527753","citation_count":2085,"is_preprint":false},{"pmid":"17296794","id":"PMC_17296794","title":"Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations.","date":"2007","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/17296794","citation_count":285,"is_preprint":false},{"pmid":"28114303","id":"PMC_28114303","title":"MFN1 structures reveal nucleotide-triggered dimerization critical for mitochondrial fusion.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28114303","citation_count":256,"is_preprint":false},{"pmid":"20661427","id":"PMC_20661427","title":"Virus-infection or 5'ppp-RNA activates antiviral signal through redistribution of IPS-1 mediated by MFN1.","date":"2010","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/20661427","citation_count":154,"is_preprint":false},{"pmid":"34195205","id":"PMC_34195205","title":"STING1 Promotes Ferroptosis Through MFN1/2-Dependent Mitochondrial Fusion.","date":"2021","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/34195205","citation_count":146,"is_preprint":false},{"pmid":"31819189","id":"PMC_31819189","title":"MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming.","date":"2019","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/31819189","citation_count":128,"is_preprint":false},{"pmid":"33667993","id":"PMC_33667993","title":"The lncRNA Malat1 regulates microvascular function after myocardial infarction in mice via miR-26b-5p/Mfn1 axis-mediated mitochondrial dynamics.","date":"2021","source":"Redox biology","url":"https://pubmed.ncbi.nlm.nih.gov/33667993","citation_count":126,"is_preprint":false},{"pmid":"25271058","id":"PMC_25271058","title":"MFN1 deacetylation activates adaptive mitochondrial fusion and protects metabolically challenged mitochondria.","date":"2014","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25271058","citation_count":119,"is_preprint":false},{"pmid":"24722297","id":"PMC_24722297","title":"MARCH5-mediated quality control on acetylated Mfn1 facilitates mitochondrial homeostasis and cell survival.","date":"2014","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/24722297","citation_count":109,"is_preprint":false},{"pmid":"31938072","id":"PMC_31938072","title":"Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31938072","citation_count":106,"is_preprint":false},{"pmid":"31947947","id":"PMC_31947947","title":"Mitochondrial Fusion Via OPA1 and MFN1 Supports Liver Tumor Cell Metabolism and Growth.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/31947947","citation_count":90,"is_preprint":false},{"pmid":"19704021","id":"PMC_19704021","title":"The BCL-2-like protein CED-9 of C. elegans promotes FZO-1/Mfn1,2- and EAT-3/Opa1-dependent mitochondrial fusion.","date":"2009","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/19704021","citation_count":88,"is_preprint":false},{"pmid":"27613809","id":"PMC_27613809","title":"Mfn1 Deficiency in the Liver Protects Against Diet-Induced Insulin Resistance and Enhances the Hypoglycemic Effect of Metformin.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27613809","citation_count":69,"is_preprint":false},{"pmid":"28057766","id":"PMC_28057766","title":"Rapid degradation of mutant SLC25A46 by the ubiquitin-proteasome system results in MFN1/2-mediated hyperfusion of mitochondria.","date":"2017","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/28057766","citation_count":68,"is_preprint":false},{"pmid":"35710796","id":"PMC_35710796","title":"FUNDC2 promotes liver tumorigenesis by inhibiting MFN1-mediated mitochondrial fusion.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35710796","citation_count":62,"is_preprint":false},{"pmid":"32802180","id":"PMC_32802180","title":"Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32802180","citation_count":60,"is_preprint":false},{"pmid":"28669827","id":"PMC_28669827","title":"Mitochondria elongation is mediated through SIRT1-mediated MFN1 stabilization.","date":"2017","source":"Cellular signalling","url":"https://pubmed.ncbi.nlm.nih.gov/28669827","citation_count":50,"is_preprint":false},{"pmid":"28803425","id":"PMC_28803425","title":"Frameshift Mutations in Repeat Sequences of ANK3, HACD4, TCP10L, TP53BP1, MFN1, LCMT2, RNMT, TRMT6, METTL8 and METTL16 Genes in Colon Cancers.","date":"2017","source":"Pathology oncology research : POR","url":"https://pubmed.ncbi.nlm.nih.gov/28803425","citation_count":47,"is_preprint":false},{"pmid":"35523862","id":"PMC_35523862","title":"The MFN1 and MFN2 mitofusins promote clustering between mitochondria and peroxisomes.","date":"2022","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/35523862","citation_count":40,"is_preprint":false},{"pmid":"32072917","id":"PMC_32072917","title":"Apoptotic Effects of Melittin on 4T1 Breast Cancer Cell Line is associated with Up Regulation of Mfn1 and Drp1 mRNA Expression.","date":"2020","source":"Anti-cancer agents in medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/32072917","citation_count":40,"is_preprint":false},{"pmid":"28112198","id":"PMC_28112198","title":"Chlorpyrifos inhibits neural induction via Mfn1-mediated mitochondrial dysfunction in human induced pluripotent stem cells.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28112198","citation_count":36,"is_preprint":false},{"pmid":"32330448","id":"PMC_32330448","title":"MFN2 Plays a Distinct Role from MFN1 in Regulating Spermatogonial Differentiation.","date":"2020","source":"Stem cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/32330448","citation_count":33,"is_preprint":false},{"pmid":"31867811","id":"PMC_31867811","title":"Resveratrol attenuates cerebral ischaemia reperfusion injury via modulating mitochondrial dynamics homeostasis and activating AMPK-Mfn1 pathway.","date":"2019","source":"International journal of experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/31867811","citation_count":32,"is_preprint":false},{"pmid":"38082266","id":"PMC_38082266","title":"Empagliflozin targets Mfn1 and Opa1 to attenuate microglia-mediated neuroinflammation in retinal ischemia and reperfusion injury.","date":"2023","source":"Journal of neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/38082266","citation_count":30,"is_preprint":false},{"pmid":"24824927","id":"PMC_24824927","title":"MicroRNA-19b targets Mfn1 to inhibit Mfn1-induced apoptosis in osteosarcoma cells.","date":"2014","source":"Neoplasma","url":"https://pubmed.ncbi.nlm.nih.gov/24824927","citation_count":28,"is_preprint":false},{"pmid":"33347533","id":"PMC_33347533","title":"miR-20b suppresses mitochondrial dysfunction-mediated apoptosis to alleviate hyperoxia-induced acute lung injury by directly targeting MFN1 and MFN2.","date":"2021","source":"Acta biochimica et biophysica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/33347533","citation_count":28,"is_preprint":false},{"pmid":"35472764","id":"PMC_35472764","title":"Mitofusins Mfn1 and Mfn2 Are Required to Preserve Glucose- but Not Incretin-Stimulated β-Cell Connectivity and Insulin Secretion.","date":"2022","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/35472764","citation_count":26,"is_preprint":false},{"pmid":"35306433","id":"PMC_35306433","title":"Baicalein suppresses high glucose-induced inflammation and apoptosis in trophoblasts by targeting the miRNA-17-5p-Mfn1/2-NF-κB pathway.","date":"2022","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/35306433","citation_count":23,"is_preprint":false},{"pmid":"30518710","id":"PMC_30518710","title":"5-Fluorouracil inhibits neural differentiation via Mfn1/2 reduction in human induced pluripotent stem cells.","date":"2018","source":"The Journal of toxicological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30518710","citation_count":21,"is_preprint":false},{"pmid":"29382326","id":"PMC_29382326","title":"Study on the inhibition of Mfn1 by plant-derived miR5338 mediating the treatment of BPH with rape bee pollen.","date":"2018","source":"BMC complementary and alternative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/29382326","citation_count":20,"is_preprint":false},{"pmid":"27133438","id":"PMC_27133438","title":"Tributyltin induces mitochondrial fission through Mfn1 degradation in human induced pluripotent stem cells.","date":"2016","source":"Toxicology in vitro : an international journal published in association with BIBRA","url":"https://pubmed.ncbi.nlm.nih.gov/27133438","citation_count":20,"is_preprint":false},{"pmid":"38555669","id":"PMC_38555669","title":"Environmental cadmium inhibits testicular testosterone synthesis via Parkin-dependent MFN1 degradation.","date":"2024","source":"Journal of hazardous materials","url":"https://pubmed.ncbi.nlm.nih.gov/38555669","citation_count":19,"is_preprint":false},{"pmid":"22245982","id":"PMC_22245982","title":"High expression of Mfn1 promotes early development of bovine SCNT embryos: improvement of mitochondrial membrane potential and oxidative metabolism.","date":"2012","source":"Mitochondrion","url":"https://pubmed.ncbi.nlm.nih.gov/22245982","citation_count":19,"is_preprint":false},{"pmid":"31781352","id":"PMC_31781352","title":"Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization.","date":"2019","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/31781352","citation_count":19,"is_preprint":false},{"pmid":"36670935","id":"PMC_36670935","title":"Genipin Attenuates Diabetic Cognitive Impairment by Reducing Lipid Accumulation and Promoting Mitochondrial Fusion via FABP4/Mfn1 Signaling in Microglia.","date":"2022","source":"Antioxidants (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/36670935","citation_count":17,"is_preprint":false},{"pmid":"29787809","id":"PMC_29787809","title":"EET enhances renal function in obese mice resulting in restoration of HO-1-Mfn1/2 signaling, and decrease in hypertension through inhibition of sodium chloride co-transporter.","date":"2018","source":"Prostaglandins & other lipid mediators","url":"https://pubmed.ncbi.nlm.nih.gov/29787809","citation_count":17,"is_preprint":false},{"pmid":"35090998","id":"PMC_35090998","title":"Lanthanum decreased VAPB-PTPP51, BAP31-FIS1, and MFN2-MFN1 expression of mitochondria-associated membranes and induced abnormal autophagy in rat hippocampus.","date":"2022","source":"Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association","url":"https://pubmed.ncbi.nlm.nih.gov/35090998","citation_count":17,"is_preprint":false},{"pmid":"39465252","id":"PMC_39465252","title":"IRF1-mediated upregulation of PARP12 promotes cartilage degradation by inhibiting PINK1/Parkin dependent mitophagy through ISG15 attenuating ubiquitylation and SUMOylation of MFN1/2.","date":"2024","source":"Bone research","url":"https://pubmed.ncbi.nlm.nih.gov/39465252","citation_count":16,"is_preprint":false},{"pmid":"38463181","id":"PMC_38463181","title":"A detailed review of pharmacology of MFN1 (mitofusion-1)-mediated mitochondrial dynamics: Implications for cellular health and diseases.","date":"2024","source":"Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society","url":"https://pubmed.ncbi.nlm.nih.gov/38463181","citation_count":16,"is_preprint":false},{"pmid":"35496076","id":"PMC_35496076","title":"Protodioscin Induces Mitochondrial Apoptosis of Human Hepatocellular Carcinoma Cells Through Eliciting ER Stress-Mediated IP3R Targeting Mfn1/Bak Expression.","date":"2022","source":"Journal of hepatocellular carcinoma","url":"https://pubmed.ncbi.nlm.nih.gov/35496076","citation_count":16,"is_preprint":false},{"pmid":"37501008","id":"PMC_37501008","title":"The immunoproteasome subunit β2i ameliorates myocardial ischemia/reperfusion injury by regulating Parkin-Mfn1/2-mediated mitochondrial fusion.","date":"2023","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/37501008","citation_count":15,"is_preprint":false},{"pmid":"34163214","id":"PMC_34163214","title":"Mitochondrial Dynamics Related Genes -MFN1, MFN2 and DRP1 Polymorphisms are Associated with Risk of Lung Cancer.","date":"2021","source":"Pharmacogenomics and personalized medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34163214","citation_count":11,"is_preprint":false},{"pmid":"35192161","id":"PMC_35192161","title":"The Mfn1-βIIPKC Interaction Regulates Mitochondrial Dysfunction via Sirt3 Following Experimental Subarachnoid Hemorrhage.","date":"2022","source":"Translational stroke research","url":"https://pubmed.ncbi.nlm.nih.gov/35192161","citation_count":11,"is_preprint":false},{"pmid":"39133213","id":"PMC_39133213","title":"Dynamic interaction of REEP5-MFN1/2 enables mitochondrial hitchhiking on tubular ER.","date":"2024","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/39133213","citation_count":10,"is_preprint":false},{"pmid":"32249375","id":"PMC_32249375","title":"Silibinin treatment results in reducing OPA1&MFN1 genes expression in a rat model hepatic ischemia-reperfusion.","date":"2020","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/32249375","citation_count":10,"is_preprint":false},{"pmid":"35686354","id":"PMC_35686354","title":"Mitoquinone mitigates paraquat-induced A549 lung epithelial cell injury by promoting MFN1/MFN2-mediated mitochondrial fusion.","date":"2022","source":"Journal of biochemical and molecular toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/35686354","citation_count":10,"is_preprint":false},{"pmid":"34425738","id":"PMC_34425738","title":"Associations between OPA1, MFN1, and MFN2 polymorphisms and primary open angle glaucoma in Polish participants of European ancestry.","date":"2021","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34425738","citation_count":9,"is_preprint":false},{"pmid":"38583647","id":"PMC_38583647","title":"Inhibition of MFN1 restores tamoxifen-induced apoptosis in resistant cells by disrupting aberrant mitochondrial fusion dynamics.","date":"2024","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38583647","citation_count":8,"is_preprint":false},{"pmid":"26682159","id":"PMC_26682159","title":"Correlation between polymorphisms in the MFN1 gene and myopia in Chinese population.","date":"2015","source":"International journal of ophthalmology","url":"https://pubmed.ncbi.nlm.nih.gov/26682159","citation_count":8,"is_preprint":false},{"pmid":"36936780","id":"PMC_36936780","title":"MFN1 augmentation prevents retinal degeneration in a Charcot-Marie-Tooth type 2A mouse model.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/36936780","citation_count":8,"is_preprint":false},{"pmid":"31466503","id":"PMC_31466503","title":"Pretreatment of bone mesenchymal stem cells with miR181-c facilitates craniofacial defect reconstruction via activating AMPK-Mfn1 signaling pathways.","date":"2019","source":"Journal of receptor and signal transduction research","url":"https://pubmed.ncbi.nlm.nih.gov/31466503","citation_count":7,"is_preprint":false},{"pmid":"39675054","id":"PMC_39675054","title":"Endogenous interactomes of MFN1 and MFN2 provide novel insights into interorganelle communication and autophagy.","date":"2024","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/39675054","citation_count":6,"is_preprint":false},{"pmid":"34864096","id":"PMC_34864096","title":"The relationship between MFN1 copy number variation and growth traits of beef cattle.","date":"2021","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/34864096","citation_count":6,"is_preprint":false},{"pmid":"37254890","id":"PMC_37254890","title":"LncRNA gadd7 promotes mitochondrial membrane potential decrease and apoptosis of alveolar type II epithelial cells by positively regulating MFN1 in an in vitro model of hyperoxia-induced acute lung injury.","date":"2023","source":"European journal of histochemistry : EJH","url":"https://pubmed.ncbi.nlm.nih.gov/37254890","citation_count":6,"is_preprint":false},{"pmid":"31609634","id":"PMC_31609634","title":"Gemini-Based Lipoplexes Complement the Mitochondrial Phenotype in MFN1-Knockout Mouse Embryonic Fibroblasts.","date":"2019","source":"Molecular pharmaceutics","url":"https://pubmed.ncbi.nlm.nih.gov/31609634","citation_count":5,"is_preprint":false},{"pmid":"39697097","id":"PMC_39697097","title":"Senolysis by GLS1 Inhibition Ameliorates Kidney Aging by Inducing Excessive mPTP Opening Through MFN1.","date":"2025","source":"The journals of gerontology. Series A, Biological sciences and medical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/39697097","citation_count":4,"is_preprint":false},{"pmid":"39739772","id":"PMC_39739772","title":"Loss of Mfn1 but not Mfn2 enhances adipogenesis.","date":"2024","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/39739772","citation_count":2,"is_preprint":false},{"pmid":"36438475","id":"PMC_36438475","title":"Erratum: Lentinan-functionalized Selenium Nanoparticles target Tumor Cell Mitochondria via TLR4/TRAF3/MFN1 pathway: Erratum.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/36438475","citation_count":2,"is_preprint":false},{"pmid":"40643535","id":"PMC_40643535","title":"Regulation of Mitochondrial Metabolism by Mfn1 Gene Encoding Mitofusin Affects Cellular Proliferation and Histone Modification.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/40643535","citation_count":1,"is_preprint":false},{"pmid":"38173217","id":"PMC_38173217","title":"Quercetin Promotes the Repair of Mitochondrial Function in H9c2 Cells Through the miR-92a-3p/Mfn1 Axis.","date":"2024","source":"Current pharmaceutical biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/38173217","citation_count":1,"is_preprint":false},{"pmid":"40714924","id":"PMC_40714924","title":"LncRNA FENDRR Inhibits Mitochondrial Apoptosis via TET2-Mediated DNA Demethylation of MFN1 in NSCPO.","date":"2025","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/40714924","citation_count":0,"is_preprint":false},{"pmid":"41361208","id":"PMC_41361208","title":"KDM6B induces demethylation of H3K27me3 in MFN1 to modulate aberrant mitophagy in sepsis-induced acute lung injury.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/41361208","citation_count":0,"is_preprint":false},{"pmid":"35730364","id":"PMC_35730364","title":"Mitochondrial dysfunction caused by targeted deletion of Mfn1 does not result in telomere shortening in oocytes.","date":"2022","source":"Zygote (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35730364","citation_count":0,"is_preprint":false},{"pmid":"41078489","id":"PMC_41078489","title":"Chronic stress-induced downregulation of MFN1 contributes to fatty liver in chickens.","date":"2025","source":"Frontiers in veterinary science","url":"https://pubmed.ncbi.nlm.nih.gov/41078489","citation_count":0,"is_preprint":false},{"pmid":"41240162","id":"PMC_41240162","title":"MYC affects mitochondrial function in IgA nephropathy by promoting the degradation of MFN1 through HRD1.","date":"2025","source":"Immunologic research","url":"https://pubmed.ncbi.nlm.nih.gov/41240162","citation_count":0,"is_preprint":false},{"pmid":"41892266","id":"PMC_41892266","title":"Effect of Hydroxyapatite Nanoparticles on the Ultrastructure, Developmental Competence, and Expression of ZP3, MFN1, and NPM2 in Vitrified Bovine GV Oocytes.","date":"2026","source":"Biology","url":"https://pubmed.ncbi.nlm.nih.gov/41892266","citation_count":0,"is_preprint":false},{"pmid":"33082914","id":"PMC_33082914","title":"Corrigendum to \"Inhibition of cAMP/PKA Pathway Protects Optic Nerve Head Astrocytes against Oxidative Stress by Akt/Bax Phosphorylation-Mediated Mfn1/2 Oligomerization\".","date":"2020","source":"Oxidative medicine and cellular longevity","url":"https://pubmed.ncbi.nlm.nih.gov/33082914","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.08.681278","title":"Structural insights into GTP-coupled conformational changes in Mfn1 revealed by time-resolved transition metal ion FRET","date":"2025-10-09","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.08.681278","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.10.27.684912","title":"Systems modeling of mitochondrial dynamics in different exercise regimes","date":"2025-10-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.27.684912","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.25.690431","title":"Mitochondrial pull-out controls mitochondrial structure in response to mitochondrial activity","date":"2025-11-28","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.25.690431","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.26.678759","title":"Non-coding exon splicing orchestrates tissue-specific expression of two functionally distinct mitochondrial isoforms of Mitofusin 2","date":"2025-09-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.26.678759","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.11.675564","title":"Human Platelet-derived Lysates and Extracellular Vesicles Restore Mitochondrial Function and Redox Balance in Neuronal Models","date":"2025-09-16","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.11.675564","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.05.21.655403","title":"Mitochondrial fusion controls the development of specialized mitochondrial structure and metabolism in rod photoreceptor cells","date":"2025-05-26","source":"bioRxiv","url":"https://doi.org/10.1101/2025.05.21.655403","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.02.11.637688","title":"Disruption of Mitochondrial Dynamics and Stasis Leads to Liver Injury and Tumorigenesis","date":"2025-02-12","source":"bioRxiv","url":"https://doi.org/10.1101/2025.02.11.637688","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.03.647131","title":"Disease-causing MFN2 mutants impair mitochondrial fission dynamics by distinct DRP1 dysregulation","date":"2025-04-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.03.647131","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.01.29.635508","title":"Time-dependent Mitochondrial Remodeling in Experimental Atrial Fibrillation and Potential Therapeutic Relevance","date":"2025-02-01","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.29.635508","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.09.10.612286","title":"Identification and Validation of Mitophagy-Related Genes in Diabetic Retinopathy","date":"2024-09-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.09.10.612286","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.10.16.617081","title":"Voluntary Exercise Attenuates Tumor Growth in a Preclinical Model of Castration-Resistant Prostate Cancer","date":"2024-10-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.10.16.617081","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.07.23.604769","title":"PA28γ promotes the malignant progression of tumor by elevating mitochondrial function via C1QBP","date":"2024-07-23","source":"bioRxiv","url":"https://doi.org/10.1101/2024.07.23.604769","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.28.625892","title":"Isoliquiritigenin attenuated cognitive impairment, cerebral tau phosphorylation and oxidative stress in a streptozotocin-induced mouse model of Alzheimer’s disease","date":"2024-11-28","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.28.625892","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.05.08.592162","title":"Human umbilical mesenchymal stem cell-derived mitochondria ameliorate maternal phenotype by improving placental mitochondria and vascular function in angiotensin II-induced preeclampsia rat","date":"2024-05-10","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.08.592162","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43953,"output_tokens":5932,"usd":0.11042},"stage2":{"model":"claude-opus-4-6","input_tokens":9510,"output_tokens":3640,"usd":0.207825},"total_usd":0.318245,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"MFN1 and MFN2 form homotypic and heterotypic complexes on the mitochondrial outer membrane and are essential for mitochondrial fusion; cells lacking Mfn1 or Mfn2 show severely reduced mitochondrial fusion, and homotypic complexes of each mitofusin are functional for fusion. Loss of either causes mitochondrial fragmentation and loss of membrane potential in a subset of mitochondria.\",\n      \"method\": \"Knockout mouse embryonic fibroblasts, rescue experiments with individual Mfn expression, mitochondrial morphology assays (live imaging), membrane potential measurements\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal genetic rescue, KO fibroblasts with defined fusion phenotype, replicated across two paralogs; foundational paper with >2000 citations\",\n      \"pmids\": [\"12527753\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Wild-type MFN1 can complement CMT2A disease-causing MFN2 mutants through formation of heterooligomeric complexes in trans between mitochondria, restoring fusion activity. Wild-type MFN2 cannot complement the same disease alleles, establishing a functional asymmetry between the two paralogs.\",\n      \"method\": \"Complementation assays in Mfn1/Mfn2 mutant MEFs, co-immunoprecipitation of heterooligomeric complexes, mitochondrial fusion assays\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional rescue and co-IP in defined mutant cells, orthogonal methods, >280 citations\",\n      \"pmids\": [\"17296794\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Crystal structures of engineered human MFN1 (GTPase domain + helical domain) reveal that GTP binding induces conformational changes promoting GTPase domain dimerization in the transition state. The helical domain resembles the 'neck' of bacterial dynamin-like proteins. A conserved aspartate residue acts as a trigger affecting mitochondrial elongation through GTP-loading-dependent domain rearrangement. Disruption of GTPase domain dimerization abolishes MFN1 fusogenic activity.\",\n      \"method\": \"X-ray crystallography of engineered MFN1 constructs in multiple nucleotide states, active-site mutagenesis, mitochondrial fusion assays in cells\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structures at multiple catalytic states combined with mutagenesis and functional fusion assays in a single study\",\n      \"pmids\": [\"28114303\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"MFN1 associates with IPS-1 (MAVS) on the mitochondrial outer membrane and positively regulates RLR-mediated innate antiviral responses. Knockdown of MFN1 abrogates virus-induced redistribution of IPS-1 into speckle-like aggregates and abolishes IFN production.\",\n      \"method\": \"siRNA knockdown of MFN1, immunofluorescence for IPS-1 redistribution, IFN production assays upon viral infection or 5'ppp-RNA transfection\",\n      \"journal\": \"PLoS pathogens\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined functional phenotype (IFN production, IPS-1 redistribution), single lab\",\n      \"pmids\": [\"20661427\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Upon glucose starvation, MFN1 associates with the deacetylase HDAC6, leading to MFN1 deacetylation and activation, which promotes mitochondrial fusion to suppress oxidative stress. HDAC6-deficient cells fail to undergo fusion-induced protection. An acetylation-resistant MFN1 mutant suppresses excess ROS production. In fasting mice, skeletal muscle mitochondria undergo dramatic fusion that is abrogated in HDAC6-knockout animals.\",\n      \"method\": \"Co-immunoprecipitation (MFN1-HDAC6), acetylation-resistant MFN1 mutant rescue, ROS measurements, mitochondrial morphology assays, HDAC6-KO mouse fasting model\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, acetylation mutant rescue, in vivo KO model, multiple orthogonal methods in single study\",\n      \"pmids\": [\"25271058\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"MARCH5 E3 ubiquitin ligase binds MFN1 and ubiquitylates it in a manner dependent on MFN1 acetylation at K491; the acetylation-deficient K491R mutant shows weak MARCH5 interaction and reduced ubiquitylation, whereas the acetylation-mimetic K491Q mutant does not. MARCH5-mediated quality control on acetylated MFN1 maintains appropriate MFN1 levels for cell survival under mitochondrial stress.\",\n      \"method\": \"Co-immunoprecipitation (MARCH5-MFN1), acetylation point mutants (K491R, K491Q), ubiquitylation assays, MARCH5-KO MEFs\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, mutagenesis of acetylation site, KO cells with functional phenotype\",\n      \"pmids\": [\"24722297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"SIRT1 deacetylase stabilizes MFN1 protein; its knockdown reduces MFN1 levels while SIRT1 overexpression increases them. TIP60 acetyltransferase promotes MFN1 acetylation and reduction, an effect abolished by co-expression of SIRT1. Under hypoxia, SIRT1 and MFN1 accumulate together, driving mitochondrial elongation. In vitro acetylation assays confirm TIP60 acetylates MFN1.\",\n      \"method\": \"siRNA knockdown and overexpression of SIRT1, in vitro acetylation assays, mitochondrial morphology assays under hypoxia\",\n      \"journal\": \"Cellular signalling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro acetylation assay plus KD/OE with phenotype, single lab\",\n      \"pmids\": [\"28669827\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"In C. elegans, the BCL-2-like protein CED-9 physically interacts with FZO-1 (the Mfn1/2 homologue) in vivo and promotes complete mitochondrial fusion (outer and inner membranes) in an FZO-1/Mfn1,2- and EAT-3/Opa1-dependent manner. Disruption of CED-9's ability to interact with FZO-1 impairs its ability to cause mitochondrial fusion.\",\n      \"method\": \"C. elegans genetics, in vivo co-immunoprecipitation (CED-9 with FZO-1), mitochondrial morphology assays, genetic epistasis with fzo-1 and eat-3 mutants\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo Co-IP plus genetic epistasis in model organism ortholog context\",\n      \"pmids\": [\"19704021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Rapid degradation of SLC25A46 by the ubiquitin-proteasome system (via E3 ligases MULAN and MARCH5, with P97 and proteasome) results in increased stability and oligomerization of MFN1 and MFN2 on the mitochondrial outer membrane, promoting mitochondrial hyperfusion. SLC25A46 thus acts as a regulator of MFN1/2 oligomerization.\",\n      \"method\": \"siRNA knockdown of SLC25A46, protein stability assays, mitochondrial morphology assays, ubiquitylation assays with MULAN and MARCH5\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with defined fusion phenotype and mechanistic follow-up on MFN1 oligomerization, single lab\",\n      \"pmids\": [\"28057766\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"STING1 accumulates in mitochondria upon erastin-induced ferroptosis and binds MFN1/2 to trigger mitochondrial fusion, leading to ROS production and lipid peroxidation. Genetic depletion of MFN1/2 (but not PINK1 or PRKN) reduces pancreatic cancer cell sensitivity to ferroptosis.\",\n      \"method\": \"Co-immunoprecipitation (STING1 with MFN1/2), genetic KO of MFN1/2, ferroptosis assays (lipid peroxidation, cell death), xenograft mouse models\",\n      \"journal\": \"Frontiers in cell and developmental biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus genetic KO with defined ferroptosis phenotype, single lab\",\n      \"pmids\": [\"34195205\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FUNDC2 directly interacts with the GTPase domain of MFN1 via its amino-terminal region, inhibiting MFN1 GTPase activity and outer mitochondrial membrane fusion. Loss of FUNDC2 leads to mitochondrial elongation and reprogrammed cellular metabolism.\",\n      \"method\": \"Co-immunoprecipitation, domain mapping, GTPase activity assay, FUNDC2 knockdown/KO with mitochondrial morphology and metabolic phenotype\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro GTPase assay, domain mapping, co-IP, and KO with defined phenotype\",\n      \"pmids\": [\"35710796\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN1 and MFN2 promote clustering between mitochondria and peroxisomes and are enriched at the mitochondria-peroxisome interface. Overexpression of MFNs increases mitochondria-peroxisome contacting sites, and a truncated MFN2 lacking the transmembrane region inhibits peroxisome tethering to mitochondria.\",\n      \"method\": \"Proximity labeling (BioID) with peroxisomal proteins, live-cell imaging of co-clustering, truncation mutant expression\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — proximity labeling plus live imaging and dominant-negative mutant, single lab\",\n      \"pmids\": [\"35523862\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Liver-specific deletion of Mfn1 (Mfn1LKO) produces a highly fragmented mitochondrial network coupled with enhanced mitochondrial respiration capacity, preference for lipid oxidation, and increased complex I abundance. Mfn1LKO mice are protected against diet-induced insulin resistance and sensitized to metformin's hypoglycemic effect.\",\n      \"method\": \"Liver-specific conditional KO mice, mitochondrial morphology assays (electron microscopy), oxygen consumption measurements, insulin tolerance tests, metformin treatment\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific KO with multiple orthogonal metabolic and morphological phenotypes\",\n      \"pmids\": [\"27613809\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"β-cell-specific double KO of Mfn1 and Mfn2 reduces mitochondrial length, glucose-induced mitochondrial polarization, ATP synthesis, and cytosolic/mitochondrial Ca2+ increases, impairing glucose-stimulated insulin secretion. Incretin/GLP-1 receptor agonists correct defective secretion through enhanced EPAC-dependent cAMP signaling, bypassing the mitochondrial defect.\",\n      \"method\": \"β-cell-selective adult-restricted dKO mice, mitochondrial morphology, ATP synthesis assays, Ca2+ imaging, cAMP sensor (Epac-camps), insulin secretion assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional dKO with multiple orthogonal physiological and imaging readouts\",\n      \"pmids\": [\"35472764\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"REEP5, an ER tubule-shaping protein, interacts with MFN1/2 to mediate mitochondrial 'hitchhiking' on tubular ER along microtubules. REEP5 depletion causes reduced ER-mitochondria tethering and increased perinuclear mitochondrial localization. Forced irreversible REEP5-MFN1/2 interaction via rapamycin-induced dimerization causes mitochondrial hyperfusion. Disruption of this interaction modulates mitochondrial ROS production.\",\n      \"method\": \"Co-immunoprecipitation (REEP5 with MFN1/2), live-cell imaging of mitochondrial distribution, rapamycin-inducible forced dimerization, REEP5 siRNA KD, ROS measurements\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, chemogenetic forced interaction, live imaging with functional consequence on ROS\",\n      \"pmids\": [\"39133213\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"MARCH5 mediates ubiquitin-dependent degradation of MFN1 in response to tributyltin (TBT) exposure, causing mitochondrial fragmentation. Knockdown of MARCH5 abolishes TBT-induced MFN1 degradation in iPSCs.\",\n      \"method\": \"siRNA knockdown of MARCH5, MFN1 protein level assays, MitoTracker mitochondrial morphology, ATP measurements in human iPSCs\",\n      \"journal\": \"Toxicology in vitro\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single KD experiment with protein level and morphology readout, mechanistically limited\",\n      \"pmids\": [\"27133438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"MFN1 interacts with BAK and with OPA1; in tamoxifen-resistant breast cancer cells, MFN1-BAK interaction is increased restraining BAK activation, while MFN1-OPA1 interaction is reduced due to augmented OPA1 proteolytic cleavage. Knockdown or pharmacological inhibition of MFN1 restores BAK oligomerization, cytochrome c release, and caspase-3/9 activation, re-sensitizing resistant cells to apoptosis.\",\n      \"method\": \"Co-immunoprecipitation (MFN1-MFN2, MFN1-OPA1, MFN1-BAK), siRNA knockdown, pharmacological inhibition, cytochrome c release assay, caspase activity assay, xenograft models\",\n      \"journal\": \"Cancer letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple Co-IPs plus functional rescue, single lab\",\n      \"pmids\": [\"38583647\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cadmium induces Parkin mitochondrial translocation, which promotes ubiquitin-dependent degradation of MFN1 protein, causing mitochondrial fusion disorder and suppressing testosterone synthesis in Leydig cells. Testis-specific Parkin knockdown prevents MFN1 degradation and mitigates testosterone decline. Mito-TEMPO (mtROS inhibitor) blocks Parkin translocation and MFN1 degradation.\",\n      \"method\": \"Parkin testis-specific KD, MFN1 overexpression, ubiquitination assays, mitochondrial morphology, testosterone measurements, Mito-TEMPO treatment in mouse model\",\n      \"journal\": \"Journal of hazardous materials\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD plus OE with mechanistic follow-up on ubiquitination, single lab\",\n      \"pmids\": [\"38555669\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Endogenous interactome profiling of MFN1-HA (CRISPR-tagged) by mass spectrometry identified novel ER, endosomal, and mitochondrial interactors of MFN1. RAB5C was validated as an endosomal modulator of mitochondrial homeostasis in interaction with MFN1/2. Interactors are regulated by nutrient deprivation.\",\n      \"method\": \"CRISPR-Cas9 endogenous HA-tagging of MFN1, HA-affinity pulldown mass spectrometry, nutrient deprivation conditions, validation of novel interactors\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — endogenous-level interactome by MS with functional validation, single lab\",\n      \"pmids\": [\"39675054\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"βIIPKC (protein kinase C βII) accumulates on the mitochondrial outer membrane, phosphorylates MFN1 at serine 86, and increases the MFN1-βIIPKC interaction after subarachnoid hemorrhage (SAH). A selective peptide antagonist of MFN1-βIIPKC association (SAMβA) attenuates neuronal injury, mitochondrial dysfunction, and protects Sirt3-dependent antioxidant activity.\",\n      \"method\": \"Co-immunoprecipitation (MFN1-βIIPKC), βIIPKC inhibitor and SAMβA peptide treatment, mitochondrial function assays, Sirt3 siRNA knockdown, in vitro and in vivo SAH models\",\n      \"journal\": \"Translational stroke research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus selective peptide antagonist with defined functional phenotype, single lab\",\n      \"pmids\": [\"35192161\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Protodioscin (PD) induces formation of an MFN1-Bak-IP3R complex on mitochondria, facilitating Ca2+ transfer from ER to mitochondria and triggering apoptosis. Downregulation of either MFN1 or Bak reverses PD-induced apoptosis and mitochondrial membrane potential loss.\",\n      \"method\": \"Co-immunoprecipitation (MFN1-Bak-IP3R), siRNA knockdown of MFN1 and Bak, flow cytometry apoptosis assay, mitochondrial membrane potential measurement\",\n      \"journal\": \"Journal of hepatocellular carcinoma\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP of tripartite complex plus KD with functional phenotype, single lab\",\n      \"pmids\": [\"35496076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Using time-resolved tmFRET in solution, GTP binding to MFN1 favors the open state (GTPase and HB1 domains far apart), while GDP+Pi results in an equilibrium between open and closed states. The nucleotide-free (apo) state adopts a conformation distinct from all nucleotide-bound states. These solution measurements reveal the full conformational cycle of MFN1 during GTP hydrolysis.\",\n      \"method\": \"Time-resolved transition metal ion FRET (tmFRET) with fluorescent non-canonical amino acid donors and metal ion acceptors, fluorescence lifetime measurements, distance distribution analysis across GDP-, GDP+Pi-, GTP-bound, and apo states\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — rigorous biophysical assay capturing full catalytic cycle in solution; preprint, not yet peer-reviewed\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Mitochondrial 'pull-out'—lateral extrusion from pre-existing mitochondrial tubules generating new mitochondrial ends as preferential fusion sites—requires both MFN1 and DRP1, and occurs predominantly at ER-mitochondria contact sites. Pull-out events are stimulated by conditions favoring oxidative phosphorylation.\",\n      \"method\": \"Live-cell imaging, MFN1 and DRP1 KO/KD, ER-mitochondria contact site visualization, metabolic perturbations\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — preprint, mechanistic assignment relies on KO and live imaging without full reconstitution\",\n      \"pmids\": [],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"MFN1 is a dynamin-related GTPase anchored in the mitochondrial outer membrane that mediates mitochondrial fusion through GTP-hydrolysis-driven conformational changes (open↔closed) promoting GTPase domain dimerization in trans between adjacent mitochondria; it forms homotypic and heterotypic complexes with MFN2, is regulated post-translationally by acetylation (written by TIP60, erased by HDAC6/SIRT1) and ubiquitylation (by MARCH5/Parkin/HRD1), interacts with IPS-1/MAVS to support antiviral signaling, with BAK and OPA1 to regulate apoptotic cytochrome c release, and with REEP5 to mediate ER-mitochondria tethering and mitochondrial cytosolic distribution.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"MFN1 is a dynamin-related GTPase anchored in the mitochondrial outer membrane that drives mitochondrial fusion through GTP-hydrolysis-dependent conformational cycling and trans-dimerization of its GTPase domains between apposing organelles [PMID:28114303]. MFN1 forms both homotypic complexes and heterotypic complexes with MFN2, with a functional asymmetry whereby MFN1 can complement disease-causing MFN2 alleles but not vice versa [PMID:12527753, PMID:17296794]. Its fusogenic activity is tuned by post-translational modifications—acetylation (written by TIP60, erased by HDAC6 and SIRT1) modulates its stability and activity, while ubiquitylation by MARCH5 and Parkin targets it for proteasomal degradation—and by direct inhibitory binding of FUNDC2 to the GTPase domain [PMID:25271058, PMID:24722297, PMID:35710796]. Beyond mitochondrial fusion, MFN1 participates in ER–mitochondria tethering via REEP5, supports MAVS-dependent innate antiviral signaling, modulates BAK-dependent apoptotic cytochrome c release, and influences metabolic homeostasis including hepatic lipid oxidation and β-cell insulin secretion [PMID:39133213, PMID:20661427, PMID:38583647, PMID:27613809, PMID:35472764].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Establishing that mammalian mitochondrial fusion requires dedicated outer-membrane GTPases resolved how mitochondrial morphology is maintained: MFN1 and MFN2 are each essential, form functional homotypic and heterotypic complexes, and their loss causes fragmentation and loss of membrane potential.\",\n      \"evidence\": \"Mfn1 and Mfn2 KO MEFs with rescue experiments, live imaging of mitochondrial fusion\",\n      \"pmids\": [\"12527753\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contribution of homotypic vs heterotypic complexes in vivo not quantified\", \"Mechanism of GTP hydrolysis in fusion not yet defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that MFN1 can complement CMT2A-linked MFN2 mutants in trans while MFN2 cannot revealed a functional asymmetry between paralogs, establishing MFN1 as the dominant fusogenic subunit in heterotypic complexes.\",\n      \"evidence\": \"Complementation assays in Mfn-null MEFs, co-immunoprecipitation of heterooligomers\",\n      \"pmids\": [\"17296794\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis for paralog asymmetry unknown\", \"Whether asymmetry holds in all tissues not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Showing that the BCL-2-family protein CED-9 physically engages FZO-1/Mfn and promotes fusion in a FZO-1- and EAT-3/OPA1-dependent manner linked apoptotic regulators to the mitochondrial fusion machinery.\",\n      \"evidence\": \"C. elegans in vivo co-IP of CED-9 with FZO-1, genetic epistasis with fzo-1 and eat-3 mutants\",\n      \"pmids\": [\"19704021\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct mammalian BCL-2/MFN1 interaction not fully recapitulated at this point\", \"Whether CED-9 activates or simply stabilizes FZO-1 unclear\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying MFN1 as a positive regulator of MAVS/IPS-1 aggregation and interferon production expanded MFN1's role beyond fusion to innate antiviral signaling on the mitochondrial outer membrane.\",\n      \"evidence\": \"MFN1 siRNA knockdown, MAVS redistribution imaging, IFN production assays upon viral challenge\",\n      \"pmids\": [\"20661427\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether MFN1's GTPase activity is required for MAVS signaling untested\", \"Physical binding interface between MFN1 and MAVS unmapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Discovery that HDAC6 deacetylates MFN1 under glucose starvation to activate fusion, while MARCH5 ubiquitylates acetylated MFN1 (at K491) for degradation, established acetylation as a central regulatory switch controlling MFN1 activity and turnover.\",\n      \"evidence\": \"Co-IP of MFN1-HDAC6, acetylation-site mutants, ROS assays, HDAC6-KO mouse fasting model; MARCH5-MFN1 co-IP and K491R/Q mutant ubiquitylation assays in KO MEFs\",\n      \"pmids\": [\"25271058\", \"24722297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full acetylation site map of MFN1 not determined\", \"Whether acetylation alters GTPase domain conformation unknown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Liver-specific Mfn1 deletion revealed that mitochondrial fragmentation paradoxically enhances respiratory capacity and lipid oxidation, protecting against diet-induced insulin resistance, demonstrating tissue-specific metabolic consequences of MFN1 loss.\",\n      \"evidence\": \"Liver-specific conditional KO mice, electron microscopy, respirometry, insulin tolerance tests\",\n      \"pmids\": [\"27613809\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How fragmented mitochondria sustain enhanced respiration mechanistically unclear\", \"Whether phenotype depends on compensatory MFN2 activity not addressed\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Crystal structures of MFN1 in multiple nucleotide states defined the GTP-hydrolysis-driven conformational cycle: GTP binding promotes GTPase domain dimerization in the transition state through a conserved aspartate trigger, directly coupling catalysis to membrane tethering.\",\n      \"evidence\": \"X-ray crystallography of engineered MFN1 constructs, active-site mutagenesis, cellular fusion assays\",\n      \"pmids\": [\"28114303\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length MFN1 structure not solved\", \"Lipid membrane context absent from crystallographic constructs\", \"How dimerization generates force for membrane merger not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of SLC25A46 as a negative regulator of MFN1/2 oligomerization showed that MFN1 activity is modulated not only by direct post-translational modifications but also by adjacent membrane proteins controlling its oligomeric state.\",\n      \"evidence\": \"SLC25A46 knockdown, MFN1 oligomerization and stability assays, mitochondrial morphology\",\n      \"pmids\": [\"28057766\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct physical interaction between SLC25A46 and MFN1 not demonstrated\", \"Mechanism of oligomerization control unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showing that SIRT1 deacetylates and stabilizes MFN1 while TIP60 acetylates it completed the writer-eraser cycle for MFN1 acetylation, linking hypoxic stress to mitochondrial elongation.\",\n      \"evidence\": \"SIRT1 KD/OE, in vitro TIP60 acetylation assays, mitochondrial morphology under hypoxia\",\n      \"pmids\": [\"28669827\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether TIP60 and HDAC6 act on the same or overlapping sites not resolved\", \"In vivo relevance of SIRT1-MFN1 axis beyond cell culture not shown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Multiple studies converged to show MFN1 integrates diverse signaling inputs: FUNDC2 directly inhibits MFN1 GTPase activity, βIIPKC phosphorylates MFN1 at S86, MFN1 interaction with BAK restrains apoptosis, and STING1 engages MFN1 to promote ferroptosis-associated fusion, revealing MFN1 as a signaling hub on the outer membrane.\",\n      \"evidence\": \"GTPase activity assays and domain mapping for FUNDC2; co-IP of MFN1-βIIPKC with peptide antagonist; co-IP of MFN1-BAK/OPA1 with KD rescue of apoptosis; co-IP of STING1-MFN1 with KO ferroptosis assays\",\n      \"pmids\": [\"35710796\", \"35192161\", \"38583647\", \"34195205\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether phosphorylation and acetylation sites interact allosterically unknown\", \"Structural basis for FUNDC2 inhibition of GTPase domain unresolved\", \"MFN1-BAK findings limited to tamoxifen-resistant breast cancer context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"β-cell-specific double KO of Mfn1/Mfn2 demonstrated that mitofusin-dependent fusion is required for glucose-stimulated ATP production and insulin secretion, a defect bypassable by incretin signaling through cAMP/EPAC.\",\n      \"evidence\": \"Adult β-cell-selective conditional dKO mice, ATP synthesis, Ca2+ imaging, insulin secretion assays\",\n      \"pmids\": [\"35472764\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Individual contributions of MFN1 vs MFN2 in β-cells not separated\", \"Long-term β-cell survival consequences not assessed\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Demonstration that MFN1/2 are enriched at mitochondria-peroxisome contact sites and promote interorganellar clustering extended MFN1's tethering role beyond homotypic mitochondrial fusion.\",\n      \"evidence\": \"BioID proximity labeling with peroxisomal markers, live-cell imaging, dominant-negative truncation mutant\",\n      \"pmids\": [\"35523862\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MFN1-peroxisomal receptor interaction not identified\", \"Functional consequence of mitochondria-peroxisome tethering on lipid metabolism not tested\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that REEP5 interacts with MFN1/2 to mediate ER-mitochondria tethering and microtubule-based mitochondrial 'hitchhiking' revealed a mechanism for cytoplasmic distribution of mitochondria coupled to ER dynamics.\",\n      \"evidence\": \"Reciprocal co-IP (REEP5-MFN1/2), rapamycin-inducible forced dimerization, live-cell imaging, ROS measurements\",\n      \"pmids\": [\"39133213\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Binding interface between REEP5 and MFN1 unmapped\", \"Whether REEP5 modulates MFN1 GTPase activity unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Endogenous MFN1 interactome profiling uncovered nutrient-regulated associations with ER, endosomal (RAB5C), and mitochondrial partners, broadening the landscape of MFN1 interorganellar contacts.\",\n      \"evidence\": \"CRISPR-tagged endogenous MFN1-HA affinity MS, validation of RAB5C, nutrient deprivation conditions\",\n      \"pmids\": [\"39675054\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Most novel interactors lack functional validation\", \"Whether RAB5C-MFN1 interaction is direct or bridged by adaptors untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A full-length MFN1 structure in a membrane context, the force-generating mechanism by which GTPase dimerization drives lipid bilayer merger, and the integrative logic by which acetylation, phosphorylation, and ubiquitylation combinatorially regulate MFN1 activity remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full-length structure of membrane-embedded MFN1\", \"Reconstituted fusion assay with purified MFN1 not achieved\", \"Combinatorial post-translational modification code not mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [2, 10, 21]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0, 2, 5, 10, 14]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [0, 1, 2, 10, 12]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [7, 16, 20]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [12, 13]}\n    ],\n    \"complexes\": [\n      \"MFN1-MFN2 heterotypic complex\",\n      \"MFN1 homotypic trans-dimer\"\n    ],\n    \"partners\": [\n      \"MFN2\",\n      \"FUNDC2\",\n      \"REEP5\",\n      \"MARCH5\",\n      \"HDAC6\",\n      \"BAK1\",\n      \"OPA1\",\n      \"MAVS\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}